Cargando…
Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
A growing body of evidence shows that altering the inflammatory response by alternative macrophage polarization is protective against complications related to acute myocardial infarction (MI). We have previously shown that oral azithromycin (AZM), initiated prior to MI, reduces inflammation and its...
Autores principales: | Al-Darraji, Ahmed, Donahue, Renée R., Tripathi, Himi, Peng, Hsuan, Levitan, Bryana M., Chelvarajan, Lakshman, Haydar, Dalia, Gao, Erhe, Henson, David, Gensel, John C., Feola, David J., Venditto, Vincent J., Abdel-Latif, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538891/ https://www.ncbi.nlm.nih.gov/pubmed/33024189 http://dx.doi.org/10.1038/s41598-020-73593-0 |
Ejemplares similares
-
Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction
por: Al‑Darraji, Ahmed, et al.
Publicado: (2021) -
Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease
por: Al-Darraji, Ahmed, et al.
Publicado: (2018) -
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
por: Venditto, Vincent J., et al.
Publicado: (2021) -
Gelatin coating enhances therapeutic cell adhesion to the infarcted myocardium via ECM binding
por: Davis, Kara A., et al.
Publicado: (2022) -
Rad GTPase Deletion Attenuates Post-Ischemic Cardiac Dysfunction and Remodeling
por: Manning, Janet R., et al.
Publicado: (2018)